Turnstone Biologics Corp. Common Stock (TSBX) Stock Forecast
Show ratings and price targets of :
Alert
Its only available to paid users.
USD 0.40
(+17.86%)
Based on the Turnstone Biologics Corp. Common Stock stock forecast from 1 analysts, the average analyst target price for Turnstone Biologics Corp. Common Stock is USD 0.40 over the next 12 months. Turnstone Biologics Corp. Common Stock’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Turnstone Biologics Corp. Common Stock is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Turnstone Biologics Corp. Common Stock’s stock price was USD 0.34. Turnstone Biologics Corp. Common Stock’s stock price has changed by -2.33% over the past week, +9.66% over the past month and -87.52% over the last year.
No recent analyst target price found for Turnstone Biologics Corp. Common Stock
No recent average analyst rating found for Turnstone Biologics Corp. Common Stock
Company Overview Turnstone Biologics Corp. Common Stock
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California. Read Less
Turnstone Biologics Corp. operates as a biotechnology company. The company was founded in 2014 and is headquartered in San Diego, California.
Frequently Asked Questions About Turnstone Biologics Corp. Common Stock (TSBX) Stock
Based on ratings from 1 analysts Turnstone Biologics Corp. Common Stock's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on TSBX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TSBX is USD 0.40 over the next 12 months. The maximum analyst target price is USD 0.4 while the minimum anlayst target price is USD 0.4.
Unfortunately we do not have enough data on TSBX's stock to indicate if its overvalued.
The last closing price of TSBX's stock was USD 0.34.
The most recent market capitalization for TSBX is USD 7.86M.
Based on targets from 1 analysts, the average taret price for TSBX is projected at USD 0.40 over the next 12 months.
This means that TSBX's stock price may go up by +17.86% over the next 12 months.
We can't find any ETFs which contains Turnstone Biologics Corp. Common Stock's stock.
As per our most recent records Turnstone Biologics Corp. Common Stock has 14 Employees.
Turnstone Biologics Corp. Common Stock's registered address is 9310 Athena Circle, San Diego, CA, United States, 92037.
You can get more information about it from Turnstone Biologics Corp. Common Stock's website at https://turnstonebio.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Turnstone Biologics Corp. Common Stock (TSBX) Stock
Based on ratings from 1 analysts Turnstone Biologics Corp. Common Stock's stock is Hold . Stock Target Advisor's fundamental analysis is Bearish. The stock has buy, sell and 1 hold ratings.
Unfortunately we do not have enough data on TSBX's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for TSBX is USD 0.40 over the next 12 months. The maximum analyst target price is USD 0.4 while the minimum anlayst target price is USD 0.4.
Unfortunately we do not have enough data on TSBX's stock to indicate if its overvalued.
The last closing price of TSBX's stock was USD 0.34.
The most recent market capitalization for TSBX is USD 7.86M.
Based on targets from 1 analysts, the average taret price for TSBX is projected at USD 0.40 over the next 12 months.
This means that TSBX's stock price may go up by +17.86% over the next 12 months.
We can't find any ETFs which contains Turnstone Biologics Corp. Common Stock's stock.
As per our most recent records Turnstone Biologics Corp. Common Stock has 14 Employees.
Turnstone Biologics Corp. Common Stock's registered address is 9310 Athena Circle, San Diego, CA, United States, 92037.
You can get more information about it from Turnstone Biologics Corp. Common Stock's website at https://turnstonebio.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for TSBX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
